Boston Scientific Announces European Approval and Launch of Platinum Chromium PROMUS® Element(TM) Stent System
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element(TM) Everolimus…
Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element(TM) Everolimus…
Eine neue, im Rahmen einer Zusammenarbeit zwischen Tecan und Forschern der Zürcher Hochschule für Angewandte Wissenschaf…